�Antidepressants ar the cornerstone of treatment of depressive disorders in health care. Their efficaciousness in treating depression is undisputable, although it leaves room for improvement. However, recent reports also suggest that antidepressants might, in some uncommon cases, actually worsen suicidal tendencies instead of alleviating them. As a consequence, research has intensified to clarify this issue, and regulatory regime in many countries get reconsidered their cost-benefit ratio. While on that point is no doubt that such potential side-effects of antidepressant therapy are a very good issue, it is important to incur a balanced view of all the clinical and epidemiological facts pertaining the effect of antidepressant therapy in relation to suicidal behaviour.
Depression and risk of exposure of self-destructive behaviour
Suicide is a significant public health issue. The World Health Organization (WHO) estimates that annually just about one meg people world-wide complete self-annihilation. Thus, world-wide significantly more people die by suicide than e.g. in armed conflicts or as victims of terror, or tragic natural disasters such as earthquakes. Furthermore, completed suicides interpret only a tip of the crisphead lettuce of self-destructive behaviour, as for every completed suicide, there is more than ten-fold bit of nonfatal suicide attempts, and as many as almost one tenth of individuals world-wide, also in the EU, report having had suicidal ideation over their lifetime (Bernal et al., 2007; Nock et al., 2008).
In legion psychological necropsy studies conducted worldwide, more than 90% of subjects completing felo-de-se were shown to have suffered from mental disorders. Suicides hold multiple causes and should therefore not be seen as but consequences of mental disorders. Nevertheless, for health care, the hard relationship between mental disorders and suicides involves an obligation for prevention. Mood disorders, principally major depression and bipolar disorder, ar associated with about 60% of completed suicides (Mann et al., 2005). More than half of the subjects completing suicide during major natural depression communicate their intent during the last 3 months, and nigh all patients attempting suicide report self-destructive ideation (Isomets� et al., 1994; Sokero et al., 2003). This communication of intent allows prevention by appropriate handling and other measures. However, the problem faced by psychiatrists is a high number of suicidal patients and the difficulty of identifying those at highest risk of completion among them.
Among psychiatric patients with major depression, nonfatal suicidal behavior is outstandingly common. Almost half (virtually 40%) have attempted self-annihilation, and one half to two thirds of them (47%-69%) have suicidal ideation (Sokero et al., 2003; Malone et al., 1995) when depressed. The risk for suicide attempts is closely intertwined with the commonly recurrent course of depression; the risk is about octuple during a major depressive episode compared to periods of total remission (Sokero et al., 2005). The more metre a patient spends in a depressed state, the higher is the risk of self-destructive acts over time. Among depressed patients having self-destructive ideation, decline in self-destructive ideation is predicted by declines in the levels of both depressive symptoms as well as hopelessness (Sokero et al., 2006).
Thus, reduction the badness and the duration of a depressed state by antidepressant treatment is probable to be an effective preventive beat for suicidal acts, and alleviation of depression and hopelessness pot be moderately expected to result in disappearance of suicidal thoughts.
Suicide prevention strategies
Depression is present in more than half of suicides, simply in the majority of these suicides it has remained untreated at time of death (Isomets� et al, 1994; Henriksson et al., 2001). Even after a self-destruction attempt, depression often corpse unrecognized, untreated or undertreated (Oquendo et al., 2002).
The function of targeting depression for suicide bar has been highlighted in a world-wide review and consensus of leading authorities in felo-de-se research, in which the effectiveness of specific suicide-preventive interventions was examined: Only physician education in realisation and treatment of depression as well as constraining access to lethal means were intelligibly identified to prevent suicide, other interventions still need more examination (Mann et al., 2005). Thus, treating mood disorders and other psychiatric disorders is a central constituent of suicide prevention.
Improved recognition and treatment of depressed patients in primary care aboard improved admission to psychiatric services is a florida key prevention strategy for self-destruction.
Antidepressants and suicide peril: what is the evidence?
In numerous short-run randomized clinical trials (RCTs) of antidepressants for depression in children and adolescents ( First, short-term clinical trials are designed to produce statistical evidence of efficaciousness for regulative purposes, and their duration is only as retentive as necessary to give rise this evidence. Thus, the trial ends when the drug response has evolved. During the trial patients spend most of their weeks with possible incline effects, simply not so far full antidepressant drug response. With regard to suicidal behaviour, the benefits come with the response, gradually o'er time.
Second, for honourable reasons, subjects who are severely self-destructive at the time of evaluation for the run must be excluded, since they mightiness receive placebo. This changes the balance between discovered negative and positive personal effects with regard to self-destructive behaviour in these trials. Worsening of mild preexisting or newly emerging self-destructive behaviour can be normally detected. However, as nigh severely suicidal patients moldiness be excluded before a trial starts, it remains unknown whether they would benefit from the active treatment. As naturalistic studies do hint such improvement, this diagonal is not merely hypothetical. Antidepressant trials have not been intentional to look into suicidal behaviour, and they cannot allow for unbiased information on their overall effects related to it.
Third, factors resulting in short-term suicidal ideation, or even less dangerous suicide attempts do non necessarily consequence in significantly increased risk for realised suicide, as mental disorders and their symptoms related to completed suicides are usually more than severe. There is no evidence of increased rates completed suicides in antidepressant trials (Khan et al, 2003).
Fourth, clinical trials do not reflect usual treatment. In usual guardianship, the attending doctor crapper promptly discontinue antidepressants that involve unendurable side-effects, adapt dosage, and switch and combine agents. Antidepressants are only portion of handling, which should always include a trusting relationship between the doctor and the patient, with necessary support and psychosocial treatments.
The most important test for the role of antidepressants in suicide prevention is real life: In contrast to these randomized clinical trials, data-based studies of antidepressant intervention, which typically include profusely highly self-destructive patients, demonstrate a marked alleviation of suicidal behaviour in the vast legal age of patients. In clinical practice, the benefits of treatment are seen over time as the dose response consolidates. Patient population studies of adolescents report lower rates of self-destruction attempts and of adults both attempts and completions over time as discussion continues (Valuck et al., 2004; Jick et al., 2004; Simon et al., 2007; Sokero et al., 2006; Simon et al., 2006).
In many western countries (e.g. Korkeila et al., 2007), increasing use of antidepressants on the national and regional level expectedly correlates with declining suicide mortality. Of course, such ecological studies do non prove that antidepressants take caused the observed decline in suicides, but still, they are uniform with a positive or at worst, neutral net effect on suicides. Most importantly, there is no evidence for increased national suicide rates due to increased enjoyment of antidepressants.
Antidepressants reduce the rigourousness, and the time a patient spends in a depressive state, which ar credible factors in reduction the risk of exposure for self-destructive acts.
Clinical implications
Depression is the most important single factor predisposing to self-destruction, and more than than half of all subjects completing suicide are known to have suffered from clinical depression. Thus, any treatment that is widely available, safe and efficacious in alleviating depression is plausible for purposes of suicide bar.
Register-based and observational studies have provided individual-level information on down subjects on and off antidepressants in real life conditions: Compared to randomised clinical trials these studies give a more realistic account of risk of suicidal behavior, and intimate antidepressants to be good for self-destruction prevention.
While antidepressants likely have a potential for provoking suicidal behaviour in some vulnerable individuals in the early phases of treatment, from a public health perspective, the epidemiologically much more important upshot of antidepressants is to alleviate depression and thus reduce the risk of suicide.
This button is available in Spanish.
References
1. Bernal M, Haro JM, Bernert S, et al.; ESEMED/ MHEDEA Investigators. Risk factors for suicidality in Europe: results from the ESEMED
